|
李哲全, 傳振宗, & 吳篤安. (2006). 糖尿病的診斷與治療. 慈濟醫學雜誌, 18(1_S), 1-9.
張嘉修，陳俊延，林志生，楊勝仲，周德珍，郭子禎，顏宏偉，李澤民. (2015).二氧化碳再利用-微藻養殖. 科學發展, 510.
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010). Pathogenesis of insulin resistance in skeletal muscle. Journal of Biomedicine and Biotechnology, 2010.
Achari, A. E., & Jain, S. K. (2017). Adiponectin, a therapeutic target for obesity,
diabetes, and endothelial dysfunction. International journal of molecular
sciences, 18 (6), 1321.
Ader, P., Blöck, M., Pietzsch, S., & Wolffram, S. (2001). Interaction of quercetin
glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). Cancer
Letters, 162 (2), 175-180.
Adeshirlarijaney, A., & Gewirtz, A. T. (2020). Considering gut microbiota in
treatment of type 2 diabetes mellitus. Gut microbes, 11(3), 253-264.
American Diabetes Association. (2004). Gestational diabetes mellitus. Diabetes care, 27 (suppl 1), 88-90.
Amitani, H., Asakawa, A., Cheng, K., Amitani, M., Kaimoto, K., Nakano, M.,
& Inui, A. (2013). Hydrogen improves glycemic control in type1 diabetic animal
model by promoting glucose uptake into skeletal muscle. PLoS One, 8(1), e53913.
Andrisse, S., Koehler, R. M., Chen, J. E., Patel, G. D., Vallurupalli, V. R., Ratliff,
B. A., & Fisher, J. S. (2014). Role of GLUT1 in regulation of reactive oxygen
species. Redox biology, 2, 764-771.
Atkinson, M. A., & Eisenbarth, G. S. (2001). Type 1 diabetes: new perspectives on disease pathogenesis and treatment. The Lancet, 358 (9277), 221-229.
Aziz, E., Batool, R., Khan, M. U., Rauf, A., Akhtar, W., Heydari, M., & Shariati,
M. A. (2020). An overview on red algae bioactive compounds and their
pharmaceutical applications. Journal of Complementary and Integrative Medicine, 17 (4).
Bailey, Clifford J., and Robert C. Turner. (1996). Metformin. New England Journal
of Medicine, 334 (9), 574-579.
Balakrishnan, B. B., Krishnasamy, K., Mayakrishnan, V., & Selvaraj, A. (2019).
Moringa concanensis Nimmo extracts ameliorates hyperglycemia-mediated
oxidative stress and upregulates PPARγ and GLUT4 gene expression in liver and
pancreas of streptozotocin-nicotinamide induced diabetic rats. Biomedicine &
pharmacotherapy, 112, 108688.
Barthel, A., & Schmoll, D. (2003). Novel concepts in insulin regulation of hepatic gluconeogenesis. American Journal of Physiology-Endocrinology and Metabolism, 285 (4), E685-E692.
Berggreen, C., Gormand, A., Omar, B., Degerman, E., & Goransson, O. (2009). Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. American Journal of Physiology-Endocrinology and Metabolism, 296(4), E635-E646.
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005). Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology, 42 (5), 987-1000.
Cai, J., Zhu, Y., Zuo, Y., Tong, Q., Zhang, Z., Yang, L., & Yi, G. (2019).
Polygonatum sibiricum polysaccharide alleviates inflammatory cytokines and
promotes glucose uptake in high glucose and high insulin induced 3T3 L1
adipocytes by promoting Nrf2 expression. Molecular medicine reports, 20 (4),
3951-3958.
Care, F. (2019). Standards of Medical Care in Diabetes 2019. Diabetes Care, 42 (Suppl 1), 124-138.
Centers for Disease Control and Prevention. (2020). National diabetes statistics report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services.
Cefalu, W. T. (2006). Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition. Institute for Laboratory Animal Research, 47 (3), 186-198.
Cicero, A. F., Tartagni, E., & Ertek, S. (2012). Metformin and its clinical use: new insights for an old drug in clinical practice. Archives of medical science: AMS, 8 (5), 907.
Chang, Y. H., Huang, C. N., & Shiau, M. Y. (2009). Cyotkines, Metabolism, and Type 2 Diabetes Mellitus. Journal of Biomedical & Laboratory Sciences, 21 (4), 112-118.
Chao, E. C. (2014). SGLT-2 inhibitors: a new mechanism for glycemic
control. Clinical Diabetes, 32(1), 4-11.
Chapman, R. L. (2013). Algae: the world’s most important “plants”—an introduction. Mitigation and Adaptation Strategies for Global Change, 18 (1), 5-12.
Charlton, M., & Nair, K. S. (1998). Protein metabolism in insulin-dependent diabetes mellitus. The Journal of nutrition, 128 (2), 323-327.
Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., Kraleti, S., Chada, A., Ravilla, R., & Sasapu, A. (2017). Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Frontiers in endocrinology, 8, 6.
Cheatham, B., & Kahn, C. R. (1995). Insulin action and the insulin signaling network. Endocrine reviews, 16 (2), 117-142.
Choi, Hyung Muk, Hari Madhuri Doss, and Kyoung Soo Kim. (2020). Multifaceted
physiological roles of adiponectin in inflammation and diseases. International journal of molecular sciences, 21 (4), 1219.
Choi, S. W., Benzie, I. F., Ma, S. W., Strain, J. J., & Hannigan, B. M. (2008). Acute
hyperglycemia and oxidative stress: direct cause and effect? Free Radical Biology
and Medicine, 44 (7), 1217-1231.
Cox, M. E., & Edelman, D. (2009). Tests for screening and diagnosis of type 2 diabetes.
Clinical diabetes, 27 (4), 132-138.
Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., & Mandarino, L. J. (2000). Insulin resistance differentially affects the PI 3-kinase–and MAP kinase–mediated signaling in human muscle. The Journal of clinical investigation, 105 (3), 311-320.
D'alessio, D. (2011). The role of dysregulated glucagon secretion in type 2 diabetes. Diabetes. Obesity and Metabolism, 13, 126-132.
Daneman, D. (2006). Type 1 diabetes. The Lancet. 367 (9513), 847-858.
DeFronzo, R. A., & Tripathy, D. (2009). Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes care, 32 (suppl 2), S157-S163.
Deng, D., & Yan, N. (2016). GLUT, SGLT, and SWEET: Structural and mechanistic
investigations of the glucose transporters. Protein Science, 25 (3), 546-558.
Derosa, G., & Maffioli, P. (2012). α-Glucosidase inhibitors and their use in clinical practice. Archives of medical science: AMS, 8 (5), 899.
Di Guglielmo, G. M., Baass, P. C., Authier, F., Posner, B. I., & Bergeron, J. J. (1998). Insulin receptor internalization and signalling. Molecular and cellular biochemistry, 182 (1-2), 59-63.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. (2005). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New England Journal of Medicine, 353(25), 2643-2653.
Drel, V. R., Mashtalir, N., Ilnytska, O., Shin, J., Li, F., Lyzogubov, V. V., & Obrosova, I. G. (2006). The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes, 55 (12), 3335-3343.
Edgerton, D. S., Ramnanan, C. J., Grueter, C. A., Johnson, K. M., Lautz, M., Neal, D. W., & Cherrington, A. D. (2009). Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo. Diabetes, 58(12), 2766-2775.
Elmadhun, N. Y., Lassaletta, A. D., Chu, L. M., Soh, I., & Sellke, F. W. (2012).
Alcohol consumption alters the insulin signaling pathway in ischemic
myocardium. Journal of the American College of Surgeons, 215 (3), S35.
Escribano-Lopez, I., Diaz-Morales, N., Iannantuoni, F., Lopez-Domenech, S., de
Marañon, A. M., Abad-Jimenez, Z., & Victor, V. M. (2018). The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes. Scientific reports, 8(1), 1-10.
Fernández-Real, J. M., & Pickup, J. C. (2008). Innate immunity, insulin resistance
and type 2 diabetes. Trends in Endocrinology & Metabolism, 19 (1), 10-16.
Fowler, M. J. (2007). Diabetes treatment, part 2: oral agents for glycemic management. Clinical diabetes, 25 (4), 131-134.
Glazer, A. N. (1977). Structure and molecular organization of the photosynthetic accessory pigments of cyanobacteria and red algae. Molecular and cellular biochemistry, 18 (2-3), 125-140.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008). Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature reviews Molecular cell biology, 9 (5), 367-377.
He, J., Xu, Y., Chen, H., & Sun, P, (2016). Extraction, structural characterization, and
potential antioxidant activity of the polysaccharides from four
seaweeds. International journal of molecular sciences, 17 (12), 1988.
Holdt, S. L., & Kraan, S. (2011). Bioactive compounds in seaweed: functional food applications and legislation. Journal of applied phycology, 23 (3), 543-597.
Huheihel, M., Ishanu, V., Tal, J., & Arad, S. M. (2002). Activity of Porphyridium sp. polysaccharide against herpes simplex viruses in vitro and in vivo. Journal of biochemical and biophysical methods, 50 (2-3), 189-200.
Jiang, G., & Zhang, B. B. (2003). Glucagon and regulation of glucose
metabolism. American Journal of Physiology-Endocrinology and Metabolism, 284(4), E671-E678.
Jiang, Z., He, P., Wu, L., Yu, G., Zhu, Y., Li, L., & Li, Q. (2021). Structural
characterization and pro-angiogenic property of a polysaccharide isolated from red seaweed Bangia fusco-purpurea. International Journal of Biological Macromolecules, 181, 705-717.
Jiang, Z., Yu, G., Liang, Y., Song, T., Zhu, Y., Ni, H., & Oda, T. (2019). Inhibitory
effects of a sulfated polysaccharide isolated from edible red alga Bangia fusco-purpurea on α-amylase and α-glucosidase. Bioscience, biotechnology, and biochemistry, 83 (11), 2065-2074.
Joslin, E. P. (1916). The treatment of diabetes mellitus. Canadian Medical Association Journal, 6 (8), 673.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2008). Continuous glucose monitoring and intensive treatment of type 1 diabetes. New England Journal of Medicine, 359 (14), 1464-1476.
Kern, P. A., Di Gregorio, G. B., Lu, T., Rassouli, N., & Ranganathan, G. (2003). Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes, 52 (7), 1779-1785.
Khalilpourfarshbafi, M., Gholami, K., Murugan, D. D., Sattar, M. Z. A., &
Abdullah, N. A. (2019). Differential effects of dietary flavonoids on
adipogenesis. European journal of nutrition, 58 (1), 5-25.
Khan, M. A. B., Hashim, M. J., King, J. K., Govender, R. D., Mustafa, H., & Al
Kaabi, J. (2020). Epidemiology of type 2 diabetes–global burden of disease and
forecasted trends. Journal of epidemiology and global health, 10 (1), 107.
Kim, S. H., Lee, S. H., & Yim, H. J. (2013). Gemigliptin, a novel dipeptidyl peptidase 4 inhibitor: first new anti-diabetic drug in the history of Korean pharmaceutical industry. Archives of pharmacal research, 36 (10), 1185-1188.
Koh, H. S. A., Lu, J., & Zhou, W. (2020). Structural dependence of sulfated
polysaccharide for diabetes management: fucoidan from Undaria pinnatifida inhibiting α-glucosidase more strongly than α-amylase and amyloglucosidase. Frontiers in Pharmacology, 11, 831.
Krycer, J. R., Yugi, K., Hirayama, A., Fazakerley, D. J., Quek, L. E., Scalzo, R.,
& James, D. E. (2017). Dynamic metabolomics reveals that insulin primes the
adipocyte for glucose metabolism. Cell reports, 21 (12), 3536-3547.
Kuo, C. H., & Li, H. Y. (2019). Diagnostic strategies for gestational diabetes mellitus: review of current evidence. Current Diabetes Reports, 19 (12), 155.
Kuo, Y. H., Lin, C. H., & Shih, C. C. (2016). Dehydroeburicoic acid from Antrodia
camphorata prevents the diabetic and dyslipidemic state via modulation of glucose transporter 4, peroxisome proliferator-activated receptor α expression and AMP-activated protein kinase phosphorylation in high-fat-fed mice. International journal of molecular sciences, 17 (6), 872.
Lee, P. T., Wen, C. M., Nan, F. H., Yeh, H. Y., & Lee, M. C. (2020).
Immunostimulatory effects of Sarcodia suiae water extracts on Nile tilapia Oreochromis niloticus and its resistance against Streptococcus agalactiae. Fish & shellfish immunology, 103, 159-168.
Leiria, L. O., & Tseng, Y. H. (2020). Lipidomics of brown and white adipose tissue:
Implications for energy metabolism. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 158788.
Little, R. R., & Sacks, D. B. (2009). HbA1c: how do we measure it and what does it
mean?. Current Opinion in Endocrinology, Diabetes and Obesity, 16 (2), 113-118.
Maneesh, A., & Chakraborty, K. (2018). Pharmacological potential of sulfated
polygalactopyranosyl-fucopyranan from the brown seaweed Sargassum wightii. Journal of Applied Phycology, 30 (3), 1971-1988.
Matveyenko, A. V., & Butler, P. C. (2008). Relationship between β‐cell mass and diabetes onset. Diabetes, Obesity and Metabolism, 10, 23-31.
McHugh, D. J. (2003). A guide to the seaweed industry. Rome: Food and Agriculture Organization of the United Nations.
Melkonian, E. A., Asuka, E., & Schury, M. P. (2019). Physiology, Gluconeogenesis.
Mellitus, D. (2005). Diagnosis and classification of diabetes mellitus. Diabetes care, 28 (S37), S5-S10.
Meng, Q., Qi, X., Chao, Y., Chen, Q., Cheng, P., Yu, X., & Bian, H. (2020).
IRS1/PI3K/AKT pathway signal involved in the regulation of glycolipid metabolic abnormalities by Mulberry (Morus alba L.) leaf extracts in 3T3-L1 adipocytes. Chinese medicine, 15 (1), 1-11.
Michalak, I., & Chojnacka, K. (2018). Introduction: Toward Algae-Based Products. In Algae Biomass: Characteristics and Applications (pp. 1-5). Springer, Cham.
Noguchi, R., Kubota, H., Yugi, K., Toyoshima, Y., Komori, Y., Soga, T., & Kuroda, S. (2013). The selective control of glycolysis, gluconeogenesis and glycogenesis by temporal insulin patterns. Molecular systems biology, 9 (1), 664.
Nopparat, J., Nualla Ong, A., & Phongdara, A. (2020). Treatment with Pluchea
indica (L.) Less. leaf ethanol extract alleviates liver injury in multiple low dose
streptozotocin induced diabetic BALB/c mice. Experimental and Therapeutic
Medicine, 20 (2), 1385-1396.
Norton, L., Shannon, C. E., Fourcaudot, M., Hu, C., Wang, N., Ren, W., & Jia,
W. (2017). Sodium‐glucose co‐transporter (SGLT) and glucose transporter
(GLUT) expression in the kidney of type 2 diabetic subjects. Diabetes, Obesity
and Metabolism, 19 (9), 1322-1326.
Olaniyi, K. S., Amusa, O. A., Akinnagbe, N. T., Ajadi, I. O., Ajadi, M. B.,
Agunbiade, T. B., & Michael, O. S. (2021). Acetate ameliorates nephrotoxicity
in streptozotocin-nicotinamide-induced diabetic rats: Involvement of xanthine
oxidase activity. Cytokine, 142, 155501.
Olokoba, A. B., Obateru, O. A., & Olokoba, L. B. (2012). Type 2 diabetes mellitus: a review of current trends. Oman medical journal, 27 (4), 269.
Pandey, A., Tripathi, P., Pandey, R., Srivatava, R., & Goswami, S. (2011).
Alternative therapies useful in the management of diabetes: A systematic
review. Journal of pharmacy & bioallied sciences, 3 (4), 504.
Percival, E., & McDowell, R. H. (1967). Chemistry and enzymology of marine algal polysaccharides.
Perry, R. J., Zhang, D., Guerra, M. T., Brill, A. L., Goedeke, L., Nasiri, A. R.,
& Shulman, G. I. (2020). Glucagon stimulates gluconeogenesis by INSP3R1-
mediated hepatic lipolysis. Nature, 579(7798), 279-283.
Pessin, J. E., & Saltiel, A. R. (2000). Signaling pathways in insulin action: molecular targets of insulin resistance. The Journal of clinical investigation, 106 (2), 165-169.
Petersen, M. C., & Shulman, G. I. (2018). Mechanisms of insulin action and insulin resistance. Physiological reviews, 98 (4), 2133-2223.
Pinkney, J. H., Stehouwer, C. D., Coppack, S. W., & Yudkin, J. S. (1997). Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes, 46 (Supplement 2), S9-S13.
Pradhan, A., Vohra, S., Vishwakarma, P., & Sethi, R. (2019). Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure. Journal of family medicine and primary care, 8 (6), 1855.
Rains, Justin L., and Sushil K. Jain. (2011). Oxidative stress, insulin signaling, and
diabetes." Free Radical Biology and Medicine, 50 (5), 567-575.
Reed, M. J., Meszaros, K., Entes, L. J., Claypool, M. D., Pinkett, J. G., Gadbois, T. M., & Reaven, G. M. (2000). A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism-Clinical and Experimental, 49 (11), 1390-1394.
Rolin, B., Larsen, M. O., Gotfredsen, C. F., Deacon, C. F., Carr, R. D., Wilken, M., & Knudsen, L. B. (2002). The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice. American Journal of Physiology-Endocrinology and Metabolism, 283 (4), E745-E752.
Rother, K. I. (2007). Diabetes treatment—bridging the divide. The New England journal of medicine, 356 (15), 1499.
Rupérez, Pilar, Eva Gómez‐Ordóñez, and Antonio Jiménez‐Escrig, (2013).
Biological activity of algal sulfated and nonsulfated polysaccharides. Bioactive
compounds from marine foods: Plant and animal sources, 219-247.
Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., & Davis, R. J. (2008). A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science, 322 (5907), 1539-1543.
Sagun KC, Juan M. & David W. (2005). Vitamin C enters mitochondria via
facilitative glucose transporter 1 (Gluti) and confers mitochondrial protection
against oxidative injury. The FASEB Journal, 19 (12), 1657-1667.
Samuel, V. T., Liu, Z. X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., & Shulman, G. I. (2004). Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. Journal of Biological Chemistry, 279 (31), 32345-32353.
Sangha, J. S., Kelloway, S., Critchley, A. T., & Prithiviraj, B. (2014). Seaweeds (macroalgae) and their extracts as contributors of plant productivity and quality: the current status of our understanding. Advances in botanical research, 71, 189-219.
Sajadimajd, S., Momtaz, S., Haratipour, P., El-Senduny, F. F., Panah, A. I., Navabi, J., & Rahimi, R. (2019). Molecular mechanisms underlying cancer preventive and therapeutic potential of algal polysaccharides. Current pharmaceutical design, 25 (11), 1210-1235.
Schinner, S., Scherbaum, W. A., Bornstein, S. R., & Barthel, A. (2005). Molecular mechanisms of insulin resistance. Diabetic Medicine, 22 (6), 674-682.
Shi, L. (2016). Bioactivities, isolation and purification methods of polysaccharides from natural products: A review. International journal of biological macromolecules, 92, 37-48.
Shih, C. C., Hwang, H. R., Chang, C. I., Su, H. M., Chen, P. C., Kuo, H. M., & Wen, Z. H. (2017). Anti-inflammatory and antinociceptive effects of ethyl acetate fraction of an edible red macroalgae Sarcodia ceylanica. International journal of molecular sciences, 18 (11), 2437.
Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. (2003). Adiponectin and protection against type 2 diabetes mellitus. The Lancet, 361 (9353), 226-228.
Srinivasan, K., & Ramarao, P. (2007). Animal model in type 2 diabetes research: An overview. Indian Journal of Medical Research, 125 (3), 451.
Stanojevic, V., & Habener, J. F. (2015). Evolving function and potential of pancreatic alpha cells. Best Practice & Research Clinical Endocrinology & Metabolism, 29 (6), 859-871.
Straub, S. G., & Sharp, G. W. (2002). Glucose‐stimulated signaling pathways in biphasic insulin secretion. Diabetes/ metabolism research and reviews, 18 (6), 451-463.
Sun, J., Liu, Y., Yu, J., Wu, J., Gao, W., Ran, L., & Wu, Y. (2019). APS could
potentially activate hepatic insulin signaling in HFD-induced IR mice. Journal of molecular endocrinology, 63 (1), 77-91.
Sun, T., Liu, J., Xie, C., Yang, J., Zhao, L., & Yang, J. (2021). Metformin attenuates
diabetic renal injury via the AMPK autophagy axis. Experimental and Therapeutic Medicine, 21 (6), 1-8.
Tanna, B., & Mishra, A. (2019). Nutraceutical potential of seaweed polysaccharides: Structure, bioactivity, safety, and toxicity. Comprehensive Reviews in Food Science and Food Safety, 18 (3), 817-831.
The Food and Drug Administration. (2005). Guidance for Industry, Estimating the
maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Center for Drug Evaluation and Research, USFDA, US Department of Health and Human Services.
Thorens, B., & Mueckler, M. (2010). Glucose transporters in the 21st
Century. American Journal of Physiology-Endocrinology and Metabolism, 298 (2), E141-E145.
Tomasik, P., & Horton, D. (2012). Enzymatic conversions of starch. Advances in carbohydrate chemistry and biochemistry, 68, 59-436.
Turner, N., Kowalski, G. M., Leslie, S. J., Risis, S., Yang, C., Lee-Young, R. S.,
& Bruce, C. R. (2013). Distinct patterns of tissue-specific lipid accumulation
during the induction of insulin resistance in mice by high-fat
feeding. Diabetologia, 56(7), 1638-1648.
Usov, A. I. (2011). Polysaccharides of the red algae. In Advances in carbohydrate chemistry and biochemistry. Academic Press, 65, 115-217.
Vallon, V., & Thomson, S. C. (2020). The tubular hypothesis of nephron filtration and
diabetic kidney disease. Nature Reviews Nephrology, 16 (6), 317-336.
Vlavcheski, F., Baron, D., Vlachogiannis, I. A., MacPherson, R. E., & Tsiani, E.
(2018). Carnosol increases skeletal muscle cell glucose uptake via AMPK-
dependent GLUT4 glucose transporter translocation. International Journal of
Molecular Sciences, 19 (5), 1321.
Vozarova, B., Stefan, N., Lindsay, R. S., Saremi, A., Pratley, R. E., Bogardus, C.,
& Tataranni, P. A. (2002). High alanine aminotransferase is associated with
decreased hepatic insulin sensitivity and predicts the development of type 2
diabetes. Diabetes, 51 (6), 1889-1895.
Wang, T., Jónsdóttir, R., Kristinsson, H. G., Hreggvidsson, G. O., Jónsson, J. Ó.,
Thorkelsson, G., & Ólafsdóttir, G. (2010). Enzyme-enhanced extraction of
antioxidant ingredients from red algae Palmaria palmata. LWT-Food Science and
Technology, 43 (9), 1387-1393.
Wanrooy, B. J., Kumar, K. P., Wen, S. W., Qin, C. X., Ritchie, R. H., & Wong, C.
H. (2018). Distinct contributions of hyperglycemia and high-fat feeding in
metabolic syndrome-induced neuroinflammation. Journal of
neuroinflammation, 15 (1), 1-13.
Wellen, K. E., Fucho, R., Gregor, M. F., Furuhashi, M., Morgan, C., Lindstad,
T., & Hotamisligil, G. S. (2007). Coordinated regulation of nutrient and
inflammatory responses by STAMP2 is essential for metabolic
homeostasis. Cell, 129 (3), 537-548.
Weykamp, C. (2013). HbA1c: a review of analytical and clinical aspects. Annals of
laboratory medicine, 33 (6), 393-400.
World Health Organization. (2019). Classification of diabetes mellitus.
Wu, J., Shi, S., Wang, H., & Wang, S. (2016). Mechanisms underlying the effect of
polysaccharides in the treatment of type 2 diabetes: A review. Carbohydrate polymers, 144, 474-494.
Yagasaki, K. (2014). Anti-diabetic phytochemicals that promote GLUT4 translocation
via AMPK signaling in muscle cells. Nutrition and Aging, 2 (1), 35-44.
Yang, M. (2020). The effects of metformin on the gastrointestinal tract (Doctoral
dissertation, University of Cambridge).
Zhang, W. Q., Zhao, T. T., Gui, D. K., Gao, C. L., Gu, J. L., Gan, W. J., & Xu,
Y. H. (2019). Sodium butyrate improves liver glycogen metabolism in type 2
diabetes mellitus. Journal of agricultural and food chemistry, 67 (27), 7694-7705.
Zhou, K., Yee, S. W., Seiser, E. L., Van Leeuwen, N., Tavendale, R., Bennett, A.
J., & Pearson, E. R. (2016). Variation in the glucose transporter gene SLC2A2
is associated with glycemic response to metformin. Nature genetics, 48 (9), 1055-
1059.
Zhang, Y., Wu, L., Ma, Z., Cheng, J., & Liu, J. (2016). Anti-diabetic, anti-oxidant
and anti-hyperlipidemic activities of flavonoids from corn silk on STZ-induced
diabetic mice. Molecules, 21 (1), 7.
|